Pharmasaga Takes the Stage at Silicon Valley's Taiwan Venture Day, Featured in On-Site Interview by Epoch Times

Pharmasaga is proud to announce that we have recently been featured in an in-depth report by Sparknify, a premier Silicon Valley-based tech media platform and innovation ecosystem operator. As one of the few Asian biotech startups highlighted by Sparknify, this feature marks a significant milestone in our international visibility.

Globally, over 589 million people suffer from diabetes, making it one of the most critical chronic diseases worldwide. However, current treatments primarily focus on controlling blood sugar levels and struggle to restore damaged pancreatic beta-cell function. The market urgently needs next-generation therapies capable of targeting the disease's...

🔗 ：［https://luma.com/fntmn0wp］

Global Pharmaceutical Companies Show Strong Interest in PS1 as Pharmasaga Advances International Licensing and Co-development Opportunities

US BIO 2026 Day 3 Report
June 24, 2026, Pacific Time

The BIO International Convention 2026 is being held from June 22 to June 25, 2026, in San Diego, California. As one of the largest global events in the biotechnology and life sciences industry, the convention provides an important platform for Pharmasaga to engage with pharmaceutical companies, investors, contract research organizations (CROs),...

Kicking off on June 22nd for four action-packed days, the Pharmasaga team is thrilled to participate once again in the premier global biotech partnering event. We are engaging with leading pharmaceutical companies, investors, and industry partners from around the world to drive our global expansion strategy. 🤝

[Wen-Chin Yang, Founder of Pharmasaga was interviewed on "Silicon Valley Night (SV9) "]

Pharmasaga recently entered into a Confidential Disclosure Agreement (CDA) with McClain, to further explore potential collaboration in the field of drug development.